Skip to content
Home/Companies/Pharma/Euticals
EU

Euticals

Pharma·Italy·Exited 2017·Held 5yr

Euticals is a pharma company, headquartered in Italy.

Entry
2012
Hold
5yr
Exit
2017
Est. EV
–

Who owns Euticals?

Euticals was owned by Clessidra Private Equity SGR through Clessidra Capital Partners II (2009 vintage) from 2012 to 2017, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-19

Clessidra Private Equity SGR
Investor
Clessidra Private Equity SGR
Clessidra Capital Partners II · 2009 · Buyout

Key facts

HQItaly
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017

More from Clessidra Capital Partners II

Other portfolio companies in the same fund.

Acetum
Exited 2017
ConsumerItaly· 2015
to
Harmont & Blaine
Exited 2022
ConsumerItaly· 2014
to
Buccellati
Exited 2019
ConsumerItaly· 2013
to
Camfin
Exited 2014
IndustrialsItaly· 2013
to
Bitolea
Exited 2017
IndustrialsItaly· 2012
to
Balconi
Exited 2015
ConsumerItaly· 2011
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
cormeo
Active
Bertelsmann InvestmentsGermany· 2025
Crossject
Active
VATEL CAPITALFrance· 2025
Data refreshed weekly · Sourced from public filings